Gene Testing

IOC Policy Restricts Transgender Women from Female Olympic Categories

The International Olympic Committee has implemented a new eligibility policy for the 2028 Los Angeles Games, limiting participation in women’s events to biological females. This policy, which mandates gene testing to determine eligibility, aims to protect fairness, safety, and integrity within the female category, acknowledging biological advantages gained from male puberty. The decision also impacts athletes with differences in sex development, such as Caster Semenya. The IOC’s stance aligns with former US President Donald Trump’s executive order on sports and reflects concerns regarding performance advantages in strength, power, and endurance.

Read More

World Athletics Gene Tests: A Misguided Attempt to Regulate Women’s Sports?

World Athletics has implemented a new policy requiring athletes to pass a one-time gene test to compete in the female category at world-ranking competitions. This test for the SRY gene, which can be conducted through a cheek swab or blood test, will be overseen by member federations and is meant to ensure that only biologically female athletes compete. This rule comes into effect on September 1st, aiming to create a level playing field, as gender cannot trump biology. This follows years of debate over eligibility criteria, with the new regulations addressing concerns about biological advantages and building on recommendations made by a working group.

Read More